COR — Cencora, Inc.

—
NYSE · Consumer Discretionary · Distributors · CIK 1140859 ·
Last close
$303.81
Market Cap
$57.98B
52W High
$375.33
52W Low
$243.78
ADV30
1,183,975
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 84,754,837,000 3,607,235,000 1,205,271,000 763,518,000 83,805,553,000 2,815,291,000 80,566,462,000
Mar 2026 — — — — — — —
Dec 2025 85,932,016,000 3,072,071,000 1,016,381,000 559,647,000 78,361,214,000 1,753,122,000 76,265,246,000
Sep 2025 83,728,554,000 2,953,577,000 945,941,000 -339,704,000 76,590,112,000 4,356,138,000 74,843,027,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,276,134,000
Investing CF
$-5,730,847,000
Financing CF
$3,553,473,000
CapEx
$-718,022,000
Dividends Paid
$-458,977,000
Buybacks
$0
EPS Diluted TTM
$13.04
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$8,491,234,000
Inventory
$20,010,006,000
Receivables
$24,893,220,000
ST Investments
—
EBIT TTM
$3,980,403,000
Pretax Income TTM
$3,506,445,000
Interest Exp TTM
$473,958,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$332,771,328,000
EBITDA
$5,546,476,032
Free Cash Flow
$2,043,314,048
Enterprise Value
$73,200,181,248
Total Cash
$2,815,290,880
Total Debt
$14,463,047,680
Shares Out
190,827,165
Trailing EPS
$13.47
Book Value
$15.99
ROE
96.9%
ROA
3.6%
Div Yield
0.75%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 321,332,819,000 3,933,622,000 1,554,169,000 76,590,112,000 74,843,027,000 1,508,019,000 3,875,120,000
Sep 2024 293,958,599,000 3,156,949,000 1,509,120,000 67,101,667,000 66,314,925,000 645,938,000 3,484,685,000
Sep 2023 262,173,411,000 2,685,605,000 1,745,293,000 62,558,746,000 61,892,459,000 522,003,000 3,911,334,000
Sep 2022 238,587,006,000 2,753,510,000 1,698,820,000 56,560,616,000 56,489,343,000 -211,559,000 2,703,088,000

TTM Snapshot

Revenues TTM
$276,706,670,000
NetIncome TTM
$2,087,879,000
OpCashFlow TTM
$0
Assets (Latest)
$76,590,112,000
Forward EPS
$19.81

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $310.00 · spot: $303.81 · call volume: 476 · put volume: 219
Expected Move to 2026-12-18: ±$44.56 (14.67%) — implied range $259.25 – $348.37 · ATM straddle on $300.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GWW W.W. GRAINGER, INC. $59.14B $1255.69 —
TEL TE Connectivity plc $62.16B $214.71 —
CAH CARDINAL HEALTH INC $51.23B $220.29 —
FERG Ferguson Enterprises Inc. /DE/ $43.97B $227.30 —
SYY SYSCO CORP $37.64B $78.57 —

News headlines (Yahoo Finance, 1h cache)

Cencora Elects Robert E. Sanchez to Its Board of Directors
2026-09-25 12:00 · Yahoo
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027
2026-09-21 23:02 · Yahoo
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
2026-09-21 10:02 · Yahoo
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch?
2026-09-19 12:38 · Yahoo
Cencora Tech Chief: AI Is Cutting Some Medical Treatment Decisions in Half
2026-09-16 19:58 · Yahoo
The Realities of Managing Enterprise AI
2026-09-15 14:29 · Yahoo
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
2026-09-24 20:22 · Yahoo
Coultreon Biopharma Appoints Nate Massari as Chief Business Officer
2026-09-14 13:00 · Yahoo
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
2026-09-28 13:18 · Yahoo
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
2026-09-25 21:22 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.